Page last updated: 2024-10-25

clobazam and Mandibular Diseases

clobazam has been researched along with Mandibular Diseases in 1 studies

Clobazam: A benzodiazepine derivative that is a long-acting GABA-A RECEPTOR agonist. It is used as an antiepileptic in the treatment of SEIZURES, including seizures associated with LENNOX-GASTAUT SYNDROME. It is also used as an anxiolytic, for the short-term treatment of acute ANXIETY.
clobazam : 7-Chloro-1H-1,5-benzodiazepine-2,4(3H,5H)-dione in which the hydrogen attached to the nitrogen at position 1 is substituted by a methyl group, whilst that attached to the other nitrogen is substituted by a phenyl group. It is used for the short-term management of acute anxiety and as an adjunct in the treatment of epilepsy in association with other antiepileptics.

Mandibular Diseases: Diseases involving the MANDIBLE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Finn, E1
Cannon, L1
Jordan, KA1

Other Studies

1 other study available for clobazam and Mandibular Diseases

ArticleYear
The treatment of trismus with Ativan: a 3-year-old with difficulty opening her mouth.
    BMJ case reports, 2018, Jul-15, Volume: 2018

    Topics: Child, Preschool; Clobazam; Dystonia; Female; Humans; Lorazepam; Mandibular Diseases; Masticatory Mu

2018